TechnipFMC R&D decreased by 35.0% to $17.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 6.8%, from $19.10M to $17.80M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a 1.5% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ1 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.20M | $18.70M | $24.00M | $14.60M | $11.50M | $19.00M | $21.90M | $15.40M | $16.80M | $17.50M | $19.30M | $17.60M | $15.20M | $15.40M | $25.20M | $19.10M | $14.10M | $22.50M | $27.40M | $17.80M |
| QoQ Change | — | -2.6% | +28.3% | -39.2% | -21.2% | +65.2% | +15.3% | -29.7% | +9.1% | +4.2% | +10.3% | -8.8% | -13.6% | +1.3% | +63.6% | -24.2% | -26.2% | +59.6% | +21.8% | -35.0% |
| YoY Change | — | — | — | — | -40.1% | +1.6% | -8.8% | +5.5% | +46.1% | -7.9% | -11.9% | +14.3% | -9.5% | -12.0% | +30.6% | +8.5% | -7.2% | +46.1% | +8.7% | -6.8% |
Range$11.50M – $27.40M
CAGR-1.6%
Avg YoY Growth+3.6%
Median YoY Growth-2.6%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Subsea | $13.30M | $14.60M | $24.10M | $18.30M | $12.80M | $20.90M | $25.70M | $16.70M |
| Surface Technologies | $1.90M | $800.00K | $1.10M | $800.00K | $1.30M | $1.60M | $1.70M | $1.10M |
| Total | $15.20M | $15.40M | $25.20M | $19.10M | $14.10M | $22.50M | $27.40M | $17.80M |
R&D at Other Companies
Frequently Asked Questions
- What is TechnipFMC's r&d?
- TechnipFMC (FTI) reported r&d of $17.80M in Q1 2026.
- How has TechnipFMC's r&d changed year-over-year?
- TechnipFMC's r&d decreased by 6.8% year-over-year, from $19.10M to $17.80M.
- What is the long-term trend for TechnipFMC's r&d?
- Over 4 years (2021 to 2025), TechnipFMC's r&d has grown at a 1.5% compound annual growth rate (CAGR), from $78.40M to $83.10M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.